422
Views
26
CrossRef citations to date
0
Altmetric
Original Artcle: Clinical

Clinical dissection of multicentric Castleman disease

, , , , , , , , , & show all
Pages 1517-1522 | Received 03 Nov 2010, Accepted 20 Mar 2011, Published online: 17 May 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Shino Fujimoto, Tomohiro Koga, Atsushi Kawakami, Hiroshi Kawabata, Shinichiro Okamoto, Masao Mizuki, Shingo Yano, Makoto Ide, Kazuko Uno, Katsumi Yagi, Toshiyuki Kojima, Minoru Mizutani, Yukihiro Tokumine, Norihiro Nishimoto, Hiroshi Fujiwara, Shin-ichi Nakatsuka, Kazuko Shiozawa, Noriko Iwaki, Yasufumi Masaki & Kazuyuki Yoshizaki. (2018) Tentative diagnostic criteria and disease severity classification for Castleman disease: A report of the research group on Castleman disease in Japan. Modern Rheumatology 28:1, pages 161-167.
Read now
Nikhil Munshi, Maneesha Mehra, Helgi van de Velde, Avinash Desai, Ravi Potluri & Jessica Vermeulen. (2015) Use of a claims database to characterize and estimate the incidence rate for Castleman disease. Leukemia & Lymphoma 56:5, pages 1252-1260.
Read now

Articles from other publishers (24)

Francis Shupo, Keith R. Abrams, Zanfina Ademi, Grace Wayi-Wayi, Natasa Zibelnik, Matt Kirchmann, Carolyn Rutherford & Kelly Makarounas-Kirchmann. (2023) Cost-Effectiveness Analysis of Siltuximab for Australian Public Investment in the Rare Condition Idiopathic Multicentric Castleman Disease. PharmacoEconomics - Open.
Crossref
Taiqin Wang, Xiaoqiang Chen, Wei Chen, Liangwen Shi & Jianzhi Liu. (2021) A retrospective study of 44 patients with head and neck Castleman’s disease. European Archives of Oto-Rhino-Laryngology 279:5, pages 2625-2630.
Crossref
Natalia A. Zapata-Salazar, Minerva Gómez-Flores, Jorge Ocampo-Candiani & Sonia Chavez-Alvarez. (2021) Cutaneous Manifestations of Castleman Disease: Histopathological Characteristics and Review of Literature. The American Journal of Dermatopathology 43:12, pages 926-931.
Crossref
Yuanyuan Jiang, Guozhu Hou, Zhaohui Zhu, Li Huo, Fang Li & Wuying Cheng. (2021) 18F-FDG PET/CT imaging features of patients with multicentric Castleman disease. Nuclear Medicine Communications 42:7, pages 833-838.
Crossref
Sevtap Tugce Ulas & Süha Dasdelen. (2021) Multizentrische Castleman-Erkrankung in Kombination mit Polyserositis und POEMS-Syndrom – Fallbericht und ÜbersichtsbeitragMulticentric Castleman’s disease combined with polyserositis and POEMS syndrome: case report and review article. Der Internist 62:7, pages 777-785.
Crossref
Miao-yan Zhang, Ming-nan Jia, Jia Chen, Jun Feng, Xin-xin Cao, Dao-bin Zhou, David C. Fajgenbaum, Lu Zhang & Jian Li. (2021) UCD with MCD-like inflammatory state: surgical excision is highly effective. Blood Advances 5:1, pages 122-128.
Crossref
Ashok Singh, Suvendu Purkait, Saumyaranjan Mallick, Prashant Ramteke, Chandan Krushna Das, Ajay Gogia, Maher Chand Sharma & Lalit Kumar. (2019) Clinicopathological Profile of Castleman’s Disease in Indian Population: Experience From a Tertiary Care Center. Indian Journal of Hematology and Blood Transfusion 36:2, pages 254-259.
Crossref
Jenna Sopfe, Ashley Endres, Kristen Campbell, Kari Hayes, Andrew T. Trout, Xiayuan Liang, Robert Lorsbach, Maureen M. O'Brien & Carrye R. Cost. (2019) Castleman disease in pediatrics: Insights on presentation, treatment, and outcomes from a two-site retrospective cohort study. Pediatric Blood & Cancer 66:5, pages e27613.
Crossref
Hee Ryong Lee, Jung Myung An, Dong Ryeol Lee, Hyun Wook Choi, Joon Seok Oh & Joong Kyung Kim. (2019) A case of Castleman disease that improved after kidney transplantation. Korean Journal of Transplantation 33:1, pages 13-18.
Crossref
Yasufumi Masaki, Hiroshi Kawabata, Shino Fujimoto, Mitsuhiro Kawano, Noriko Iwaki, Takeharu Kotani, Akikatsu Nakashima, Nozomu Kurose, Kazue Takai, Ritsuro Suzuki & Sadao Aoki. (2019) Epidemiological analysis of multicentric and unicentric Castleman disease and TAFRO syndrome in Japan. Journal of Clinical and Experimental Hematopathology 59:4, pages 175-178.
Crossref
Frits van Rhee, Peter VoorheesAngela DispenzieriAlexander FossåGordan SrkalovicMakoto IdeNikhil MunshiStephen ScheyMatthew StreetlySheila K. PiersonHelen L. PartridgeSudipto MukherjeeDustin ShillingKatie StoneAmy GreenwayJason RuthMary Jo Lechowicz, Shanmuganathan ChandrakasanRaj JayanthanElaine S. JaffeHeather LeitchNaveen PemmarajuAmy ChadburnMegan S. Lim, Kojo S. Elenitoba-Johnson, Vera KrymskayaAaron GoodmanChristian HoffmannPier Luigi ZinzaniSimone FerreroLouis TerriouYasuharu SatoDavid SimpsonRaymond Wong, Jean-Francois RossiSunita NastaKazuyuki YoshizakiRazelle KurzrockThomas S. UldrickCorey Casper, Eric Oksenhendler & David C. Fajgenbaum. (2018) International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease. Blood 132:20, pages 2115-2124.
Crossref
Sheila K. Pierson, Aaron J. Stonestrom, Dustin Shilling, Jason Ruth, Christopher S. Nabel, Amrit Singh, Yue Ren, Katie Stone, Hongzhe Li, Frits van Rhee & David C. Fajgenbaum. (2018) Plasma proteomics identifies a ‘chemokine storm’ in idiopathic multicentric Castleman disease. American Journal of Hematology 93:7, pages 902-912.
Crossref
Xuanye Zhang, Huilan Rao, Xiaolu Xu, Zhihua Li, Bing Liao, Hongmei Wu, Mei Li, Xiuzhen Tong, Juan Li & Qingqing Cai. (2018) Clinical characteristics and outcomes of Castleman disease: A multicenter study of 185 Chinese patients. Cancer Science 109:1, pages 199-206.
Crossref
Eric Oksenhendler, David Boutboul, David Fajgenbaum, Adrien Mirouse, Claire Fieschi, Marion Malphettes, Laetitia Vercellino, Véronique Meignin, Laurence Gérard & Lionel Galicier. (2018) The full spectrum of Castleman disease: 273 patients studied over 20 years. British Journal of Haematology 180:2, pages 206-216.
Crossref
Wan Cheol Ryu, Moon Hyang Park, Hoon Kim, In Chang Koh & Kyu Nam Kim. (2017) Rare Location of Castleman&'s Disease in the Temporal Region: A Case Report Involving a Young Korean Woman and Review of the Literature. Archives of Craniofacial Surgery 18:2, pages 122-127.
Crossref
Li YuMeifeng TuJorge Cortes, Zijun Y. Xu-MonetteRoberto N. MirandaJun ZhangRobert Z. OrlowskiSattva NeelapuPrajwal C. Boddu, Mary A. Akosile, Thomas S. UldrickRobert YarchoanL. Jeffrey MedeirosYong LiDavid C. Fajgenbaum & Ken H. Young. (2017) Clinical and pathological characteristics of HIV- and HHV-8–negative Castleman disease. Blood 129:12, pages 1658-1668.
Crossref
Seth J. Kligerman, Aaron Auerbach, Teri J. Franks & Jeffrey R. Galvin. (2016) Castleman Disease of the Thorax: Clinical, Radiologic, and Pathologic Correlation: From the Radiologic Pathology Archives . RadioGraphics 36:5, pages 1309-1332.
Crossref
Jin mei Luo, Shan Li, Hui Huang, Jian Cao, Kai Xu, Ya lan Bi, Rui e Feng, Cheng Huang, Ying zhi Qin, Zuo jun Xu & Yi Xiao. (2015) Clinical spectrum of intrathoracic Castleman disease: a retrospective analysis of 48 cases in a single Chinese hospital. BMC Pulmonary Medicine 15:1.
Crossref
Chao Liu, Yi Ran Liu, Jian Chen, Shao Yang Zhuo, Martin Dalin, Shao Hua Liu & Feng Cai Wei. (2014) Inhibitor of differentiation 1 is a candidate prognostic marker in multicentric Castleman’s disease. Annals of Hematology 93:7, pages 1177-1183.
Crossref
Seyoung SeoChanghoon YooDok Hyun YoonShin KimJung Sun ParkChan-Sik ParkJooryung HuhCheolwon Suh. (2014) Clinical features and outcomes in patients with human immunodeficiency virus-negative, multicentric Castleman's disease: a single medical center experience. Blood Research 49:4, pages 253.
Crossref
Eun Seong Lee, Jin Chul Paeng, Chang Min Park, Won Chang, Won Woo Lee, Keon Wook Kang, June-Key Chung & Dong Soo Lee. (2013) Metabolic Characteristics of Castleman Disease on 18F-FDG PET in Relation to Clinical Implication. Clinical Nuclear Medicine 38:5, pages 339-342.
Crossref
Hiroshi Kawabata, Norimitsu Kadowaki, Momoko Nishikori, Toshio Kitawaki, Tadakazu Kondo, Takayuki Ishikawa, Hajime Yoshifuji, Noriyuki Yamakawa, Yoshitaka Imura, Tsuneyo Mimori, Yumi Matsumura, Yoshiki Miyachi, Takeshi Matsubara, Motoko Yanagita, Hironori Haga & Akifumi Takaori-Kondo. (2013) Clinical Features and Treatment of Multicentric Castleman's Disease : A Retrospective Study of 21 Japanese Patients at a Single Institute. Journal of Clinical and Experimental Hematopathology 53:1, pages 69-77.
Crossref
Angela Dispenzieri, James O. Armitage, Matt J. Loe, Susan M. Geyer, Jake Allred, John K. Camoriano, David M. Menke, Dennis D. Weisenburger, Kay Ristow, Ahmet Dogan & Thomas M. Habermann. (2012) The clinical spectrum of Castleman's disease. American Journal of Hematology 87:11, pages 997-1002.
Crossref
Theresa W. Muskardin, Bruce A. Peterson & Jerry A. Molitor. (2012) Castleman disease and associated autoimmune disease. Current Opinion in Rheumatology 24:1, pages 76-83.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.